Fennec Medical

Company Overview

Snapshot

Founded in January 2023 by Nir Karasikov, PhD, Nadav Cohen, and Jim Dick, Fennec Medical operates with 1–10 employees. The company has secured funding across four rounds, including a Pre-Seed round in August 2023. Fennec Medical also received a grant in October 2024, signaling ongoing development and support for its innovative medical technology.

Business overview

Fennec Medical is a digital surgery company focused on transforming orthopedic procedures through an AI Surgical Assistant. The company's core technology, Echostem, is a wireless, disposable instrument designed to provide real-time, objective data on bone-implant interaction, replacing subjective surgical feel with deterministic insights. This AI Surgical Co-pilot delivers continuous, actionable guidance and pre-fracture alerts, empowering surgeons with clinical certainty. Fennec Medical serves the healthcare industry, specifically targeting orthopedic surgery within the medical devices and digital healthcare sectors, aiming to address a significant global burden and reduce hospital costs associated with early mechanical failures.

Company Intelligence Q&A

What is Fennec Medical's primary focus?

Fennec Medical develops an AI Surgical Assistant designed to enhance real-time decision-making during orthopedic procedures, aiming to transform high-risk art into predictable science.

When was Fennec Medical founded?

Fennec Medical was founded in January 2023.

Who are the founders of Fennec Medical?

Fennec Medical was founded by Nir Karasikov, PhD, Nadav Cohen, and Jim Dick.

What is Echostem?

Echostem is a wireless, disposable instrument developed by Fennec Medical that listens to bone-implant interaction, powering the AI Surgical Co-pilot to provide continuous, actionable guidance and pre-fracture alerts.

Has Fennec Medical received any grants?

Yes, Fennec Medical received a grant in October 2024, following another grant in March 2024 and an initial grant in January 2023.